Patent Assignment
Reel/Frame 032319/0077
Security Agreement
Recorded: 2014-02-21
Pages: 8
Assignor
CREALTA PHARMACEUTICALS LLC
Executed: 2014-02-21
Assignee
JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
520 MADISON AVENUE, NEW YORK, NEW YORK, 10022
Covered Properties
(21)
Method for Ameliorating Muscle Weakness/Wasting in a Patient Infected with Human Immunodeficiency Virus-Type 1
Patent:
6,090,799 →
Application:
08/244,988 →
Use of Oxandrolone in the Treatment of Burns and Other Wounds
Patent:
6,576,659 →
Application:
08/985,734 →
Use of Oxandrolone in the Treatment of Chronic Obstructive Pulmonary Disease
Patent:
5,872,147 →
Application:
08/986,015 →
Method for Ameliorating Muscle Weakness/Wasting in a Patient Infected with Human Immunodeficiency Virus-Type 1
Patent:
6,670,351 →
Application:
09/469,817 →
Use of Oxandrolone in the Treatment of Burns and Other Wounds
Specific Human Antibodies for Selective Cancer Therapy
Use of Oxandrolone in the Treatment of Burns and Other Wounds
Use of Oxandrolone in the Treatment of Burns and Other Wounds
Antibodies and uses thereof
Application:
11/166,740 →
Publication:
US 2005/0266009
Methods for Lowering Elevated Uric Acid Levels Using Intravenous Injections of Peg-Uricase
Purification of Proteins With Cationic Surfactant
Variant Form of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Variant Form of Urate Oxidase and Use Thereof
Variant Form of Urate Oxidase and Use Thereof
Variant Form of Urate Oxidase and Use Thereof
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Variant Form of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Variant Form of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 20, 1994
From: BERGER, JOSEPH R.
To: BTG PHARMACEUTICALS CORP.
Reel/Frame 007697/0179 →
Assignment of Assignor's Interest
Jun 9, 1998
From: BOWEN, ROBERT E.
To: BIO-TECHNOLOGY GENERAL CORP.
Reel/Frame 009520/0309 →
Assignment of Assignor's Interest
Jun 19, 1998
From: FISHBEIN, DON
To: BIO-TECHNOLOGY GENERAL CORP.
Reel/Frame 009271/0541 →
Merger & Change of Name
Feb 14, 2000
From: BTG PHARMACEUTICALS CORP.
To: BIO-TECHNOLOGY GENERAL CORP.
Reel/Frame 010615/0799 →
Assignment of Assignor's Interest
Aug 20, 2002
From: HAGAY, YOCHEVED; LAZAROVITS, JANETTE; LIFSHITZ, ORLY; GUY, RACHEL
To: BIO-TECHNOLOGY GENERAL, INC.
Reel/Frame 013209/0794 →
Change of Name
Oct 20, 2003
From: BIO-TECHNOLOGY GENERAL, INC.
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 014611/0880 →
Change of Name
Jan 16, 2004
From: BIO-TECHNOLOGY GENERAL CORP.
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 014871/0808 →
Change of Name
Jun 21, 2004
From: BIO-TECHNOLOGY GENERAL CORP.
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 014754/0469 →
Change of Name
Dec 7, 2005
From: SAVIENT PHARMACEUTICALS, INC.
To: BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
Reel/Frame 017100/0091 →
Assignment of Assignor's Interest
Aug 28, 2007
From: REHRIG, CLAUDIA D.; HUANG, WILLIAM; HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 019756/0045 →
Assignment of Assignor's Interest
Jan 18, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020386/0145 →
Assignment of Assignor's Interest
Jan 18, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020384/0974 →
Assignment of Assignor's Interest
Jan 18, 2008
From: FISCHER, MEIR; HAROSH, ELIYAHU
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020383/0946 →
Assignment of Assignor's Interest
Jul 23, 2008
From: HERSHFIELD, MICHAEL S.
To: DUKE UNIVERSITY
Reel/Frame 021278/0683 →
Security Agreement
Jun 12, 2012
From: SAVIENT PHARMACEUTICALS, INC.
To: MORGAN STANLEY SENIOR FUNDING INC.
Reel/Frame 028363/0040 →
Assignment of Assignor's Interest
Aug 3, 2012
From: ROSARIO-JANSEN, THERESA; WRIGHT, DAVID ERICK
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 028715/0585 →
Corrective Assignment to Correct the Receiving Party Previously Recorded on Reel 028363 Frame 0040. Assignor(S) Hereby Confirms the Security Agreement.
Jul 23, 2013
From: SAVIENT PHARMACEUTICALS, INC.
To: U.S. NATIONAL BANK ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 030936/0072 →
Security Agreement
Mar 4, 2014
From: CREALTA PHARMACEUTICALS LLC
To: FIFTH STREET FINANCE CORP., AS COLLATERAL AGENT
Reel/Frame 032384/0285 →
Assignment of Assignor's Interest
Apr 15, 2014
From: SAVIENT PHARMACEUTICALS, INC.; SAVIENT PHARMA HOLDINGS, LLC
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 032675/0936 →
Release of Security Interest
Aug 10, 2015
From: U.S. BANK NATIONAL ASSOCIATION
To: SAVIENT PHARMA HOLDINGS, INC.
Reel/Frame 036316/0906 →
Release of Security Interest
Aug 10, 2015
From: U.S. BANK NATIONAL ASSOCIATION
To: SAVIENT PHARMACEUTICAL, INC.
Reel/Frame 036317/0049 →
Assignment of Assignor's Interest
Aug 11, 2015
From: SAVIENT PHARMACEUTICALS, INC.; SAVIENT PHARMA HOLDINGS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 036328/0001 →
Release of Security Interest
Aug 11, 2015
From: JEFFERIES FINANCE LLC
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 036296/0750 →
Release of Security Interest
Aug 11, 2015
From: FIFTH STREET FINANCE CORP.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 036297/0163 →
Assignment of Assignor's Interest
Aug 11, 2015
From: CREALTA PHARMACEUTICALS LLC
To: GEMINI LABORATORIES LLC
Reel/Frame 036297/0453 →